IOVA
USDIovance Biotherapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$2.250
Máximo
$2.380
Mínimo
$2.080
Volumen
17.39M
Fundamentos de la Empresa
Capitalización de Mercado
913.0M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
13.73M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif., Nov. 03, 2025
HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $9
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics with a Buy and lowers the price target from $20 to $9.
Acciones Relacionadas
ANIP
ANI Pharmaceuticals Inc.
TW
Tradeweb Markets Inc.
KNSL
Kinsale Capital Group Inc.
CHH
Choice Hotels International Inc.
NGL
NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.